| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Soleno Therapeutics, Inc. (SLNO) has 9 insiders with recent SEC Form 4 filings, including 6 buys and 0 sells. SLNO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 569.5K | $30.19M | - | |
| CFO | 103.2K | $5.47M | - | |
| Other | 72.3K | $3.83M | - | |
| Other | 67.2K | $3.56M | - | |
| Other | 64.3K | $3.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2015 | Mario Ernest | Director, 10% Owner | Buy | 16,228 | $1.91 | $30,995.48 | +1.1% | |
| Aug 12, 2015 | Anish Bhatnagar | See Remarks | Buy | 10,000 | $1.64 | $16,400.00 | New | |
| Aug 12, 2015 | Mario Ernest | Director, 10% Owner | Buy | 10,000 | $1.64 | $16,440.00 | +0.8% | |
| Aug 11, 2015 | O'Toole David D47 | See Remarks | Buy | 10,000 | $1.78 | $17,800.00 | +190.5% | |
| Aug 11, 2015 | Mario Ernest | Director, 10% Owner | Buy | 50,000 | $1.77 | $88,500.00 | +3.9% | |
| Mar 13, 2015 | O'Toole David D47 | Chief Financial Officer | Buy | 5,250 | $6.23 | $32,707.50 | New |